Spots Global Cancer Trial Database for stage iii ovarian cancer
Every month we try and update this database with for stage iii ovarian cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Ovarian Cancer Patient-Centered Decision Aid | NCT02259699 | Stage III Ovari... | Decision Aid | 21 Years - | University of California, Irvine | |
| Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis | NCT02441140 | Stage III Ovari... Stage IV Ovaria... | Culdocentesis Vaginal Swab Chromopertubati... Blood collectio... Tissue collecti... | 18 Years - | Dana-Farber Cancer Institute | |
| Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer | NCT01196429 | Ovarian Clear C... Stage III Ovari... Stage IV Ovaria... | Carboplatin Docetaxel Laboratory Biom... Paclitaxel Temsirolimus | 18 Years - | National Cancer Institute (NCI) | |
| Salvage Ovarian FANG™ Vaccine + Bevacizumab | NCT01551745 | Stage III Ovari... Stage IV Ovaria... | Vigil™ Vaccine Bevacizumab | 18 Years - | Gradalis, Inc. | |
| A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) | NCT05429970 | Ovarian Cancer Ovarian Carcino... Stage II Ovary ... Stage II Ovaria... Stage III Ovary... Stage III Ovari... Stage IV Ovary ... Stage IV Ovaria... Epithelial Ovar... Fallopian Tube ... Stage II Fallop... Stage III Fallo... Stage IV Fallop... Primary Periton... | Mind-body resil... Music therapy Propranolol Etodolac | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Phase 1 Trial of Perfusion Induced Systemic Hyperthermia (PISH) Over Multiple Cycles for Terminal Ovarian Cancer | NCT02093871 | Ovarian Cancer | ThermalCore Hyp... | 18 Years - 69 Years | ThermalCore Inc | |
| Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer | NCT00352300 | Fallopian Tube ... Infectious Diso... Neutropenia Ovarian Carcino... Primary Periton... Stage III Ovari... Stage IV Ovaria... | Adjuvant Therap... Carboplatin Paclitaxel Pegfilgrastim | 18 Years - | GOG Foundation | |
| Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer | NCT03297489 | Fallopian Tube ... Primary Periton... Stage I Ovarian... Stage IA Ovaria... Stage IB Ovaria... Stage IC Ovaria... Stage II Ovaria... Stage IIA Ovari... Stage IIB Ovari... Stage IIC Ovari... Stage III Ovari... Stage IIIA Ovar... Stage IIIB Ovar... Stage IIIC Ovar... Stage IV Ovaria... | Diagnostic Micr... Fluorescein Sod... Laboratory Biom... | 18 Years - | Roswell Park Cancer Institute | |
| IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery | NCT03029611 | Stage III Fallo... Stage III Ovari... Stage III Prima... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... | Carboplatin Gynecological S... Laboratory Biom... Paclitaxel pUMVC3-hIGFBP-2... | 18 Years - | University of Washington | |
| Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer | NCT01650376 | Stage III Ovari... Stage IV Ovaria... Uterine Cancer | Olaparib Carboplatin Paclitaxel | 18 Years - | Swedish Medical Center | |
| Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer | NCT01196429 | Ovarian Clear C... Stage III Ovari... Stage IV Ovaria... | Carboplatin Docetaxel Laboratory Biom... Paclitaxel Temsirolimus | 18 Years - | National Cancer Institute (NCI) | |
| Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer | NCT01196429 | Ovarian Clear C... Stage III Ovari... Stage IV Ovaria... | Carboplatin Docetaxel Laboratory Biom... Paclitaxel Temsirolimus | 18 Years - | National Cancer Institute (NCI) | |
| Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer | NCT00060359 | Fallopian Tube ... Malignant Ovari... Ovarian Brenner... Ovarian Clear C... Ovarian Endomet... Ovarian Mucinou... Ovarian Serous ... Primary Periton... Stage III Ovari... Stage IV Ovaria... Undifferentiate... | Carboplatin Paclitaxel Poli... Pharmacological... | 18 Years - | GOG Foundation | |
| Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors | NCT00301756 | Fallopian Tube ... Primary Periton... Recurrent Borde... Recurrent Ovari... Stage III Borde... Stage III Ovari... Stage IV Border... Stage IV Ovaria... | Belinostat Laboratory Biom... | 18 Years - | National Cancer Institute (NCI) | |
| IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery | NCT03029611 | Stage III Fallo... Stage III Ovari... Stage III Prima... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... | Carboplatin Gynecological S... Laboratory Biom... Paclitaxel pUMVC3-hIGFBP-2... | 18 Years - | University of Washington | |
| Ovarian Cancer Patient-Centered Decision Aid | NCT02259699 | Stage III Ovari... | Decision Aid | 21 Years - | University of California, Irvine | |
| Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy | NCT04204811 | Ovarian Cancer Stage III Ovari... Stage IV Ovaria... Primary Periton... Fallopian Tube ... Fallopian Tube ... | Prehabilitation | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) | NCT05429970 | Ovarian Cancer Ovarian Carcino... Stage II Ovary ... Stage II Ovaria... Stage III Ovary... Stage III Ovari... Stage IV Ovary ... Stage IV Ovaria... Epithelial Ovar... Fallopian Tube ... Stage II Fallop... Stage III Fallo... Stage IV Fallop... Primary Periton... | Mind-body resil... Music therapy Propranolol Etodolac | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer | NCT03297489 | Fallopian Tube ... Primary Periton... Stage I Ovarian... Stage IA Ovaria... Stage IB Ovaria... Stage IC Ovaria... Stage II Ovaria... Stage IIA Ovari... Stage IIB Ovari... Stage IIC Ovari... Stage III Ovari... Stage IIIA Ovar... Stage IIIB Ovar... Stage IIIC Ovar... Stage IV Ovaria... | Diagnostic Micr... Fluorescein Sod... Laboratory Biom... | 18 Years - | Roswell Park Cancer Institute | |
| Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy | NCT00551265 | Fallopian Tube ... Primary Periton... Recurrent Ovari... Stage III Ovari... Stage IV Ovaria... | Cyclophosphamid... Laboratory Biom... Oregovomab | 18 Years - | GOG Foundation | |
| To Explore the Feasibility of Dynamic Changes of TCR Diversity in Peripheral Blood in Monitoring Recurrence and Evaluating Prognosis of Epithelial Ovarian Cancer | NCT06315270 | Epithelial Ovar... Stage III Ovari... Stage IV Ovaria... | 18 Years - 75 Years | The First Hospital of Jilin University | ||
| Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis | NCT02441140 | Stage III Ovari... Stage IV Ovaria... | Culdocentesis Vaginal Swab Chromopertubati... Blood collectio... Tissue collecti... | 18 Years - | Dana-Farber Cancer Institute | |
| Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer | NCT00003532 | Stage III Ovari... Stage IV Ovaria... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Ask Questions (ASQ):Implementation of a Communication Intervention | NCT05025748 | Stage II Breast... Stage III Breas... Stage IV Breast... Stage II Colore... Stage III Color... Stage IV Colore... Stage II Lung C... Stage III Lung ... Stage IV Lung C... Stage II Prosta... Stage III Prost... Stage IV Prosta... Stage II Ovaria... Stage III Ovari... Stage IV Ovaria... Stage II Cervic... Stage III Cervi... Stage II Bladde... Stage III Bladd... Stage IV Bladde... Stage II Kidney... Stage III Kidne... Stage IV Kidney... | Behavioral Inte... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer | NCT05659381 | Stage III Ovari... Stage IV Ovaria... Stage III Prima... Stage IV Primar... Stage III Fallo... Stage IV Fallop... | Cisplatin No treatment | 18 Years - | GOG Foundation | |
| 18F-DCFPyL PET/CT in High-grade Epithelial Ovarian Cancer (PET HOC) | NCT03811899 | Stage III Ovari... Stage IV Ovaria... | 18F-DCFPyL | 18 Years - | University Health Network, Toronto |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
